ZONGULDAK BULENT ECEVIT UNIVERSITY
Digital Data Management System
Academic Competence
Contact information

birsen.sahip

2612001-2357

International Proceedings
Is Higher IL 21 Level Predictive of Relapses in Immune Thrombocytopenia and is it Associated with the Activation of the Complement System

PAMUK GÜLSÜM EMEL, SAHİP BİRSEN, UYANIK MEHMET ŞEVKİ, DEMİR AHMET MUZAFFER, PAMUK ÖMER NURİ
19th Congress of the European Hematology Association | Elektronik | 2014-06-14 - 2014-06-16

Flow cytometry analysis of the acute EBV infecton among patients with haematological disorders

BİLİCİ MUAMMER, Delikanli Corakci Basak, ÖZTÜRK YASİN, SAHİP BİRSEN, KURT CEM (2 more authors)
. IX. International Eurasian Hematology-Oncology Congress. 17-20 October 2018 ,İstanbul | Sözlü Sunum | Basılı+Elektronik | ISBN 0145-2126 | 2018-10-17 - 2018-10-20 | 20.10.2018

Original versus generic lenalidomide in patients with relapsed multiple myeloma: comparison of effectivity and adverse events

BOLAMAN ALİ ZAHİT, ERTOP ŞEHMUS, SELİM CEM, TURGUTKAYA ATAKAN, SAHİP BİRSEN (1 more authors)
Xth Eurasian Hematology Oncology Congress | Sözlü Sunum | Elektronik | 2019-10-08 - 2019-10-11 | 08.10.2019

Original Versus Generic Lenalidomide in Patients with Relapsed Multipl Myeloma: Comprasion of Effectivity and Adverse Events

BOLAMAN ALİ ZAHİT, ertop şehmuz, TURGUTKAYA ATAKAN, SELİM CEM, küçükerdiler ayşe hilal erdoğdu (2 more authors)
International Eurasian Hematology Oncology Congress | Sözlü Sunum | 2019-10-09 - 2019-10-12 | 09.10.2019

Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

TOMBAK ANIL, FUNDA PEPEDİL, DURUSOY SALİH SERTAÇ, GÜRKAN EMEL, KAYA EMİN (38 more authors)
ASH | Poster | Basılı+Elektronik | 2019-12-07 - 2019-12-10 | 13.11.2019

Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences

TOMBAK ANIL, PEPEDİL TANRIKULU FUNDA, DURUSOY SALİH SERTAÇ, GÜRKAN EMEL, KAYA ELİF (37 more authors)
Results of a Prospective Multicenter Study. 61st ASH Annual Meeting | Poster | Basılı | 2019-12-07 - 2019-12-10 | 10.12.2019

THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA IN PATIENTS WITH LOW-RISK OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROME: RETROSPECTIVE MULTI-CENTER REAL-LIFE STUDY

ASLANER AK MÜZEYYEN, SAHİP BİRSEN, GEDÜK AYFER, UÇAR MEHMET ALİ, KALE HACER (6 more authors)
XIV. Eurasian Hematology Oncology Congress | Poster | Elektronik | 2023-10-11 - 2023-10-14 | 11.10.2023

THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA IN PATIENTS WITH LOW-RISK OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROME: RETROSPECTIVE MULTI-CENTER REAL-LIFE STUDY

ASLANER AK MÜZEYYEN, SAHİP YESİRALİOĞLU BİRSEN , GEDÜK AYFER, UÇAR MEHMET ALİ, HACIBEKİROĞLU TUBA (5 more authors)
XIV Eurasian Hematology Oncology Congress | Poster | Basılı | 2023-10-11 - 2023-10-14 | 14.10.2023

THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA IN PATIENTS WITH LOW-RISK OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROME: RETROSPECTIVE MULTI-CENTER REAL-LIFE STUDY

ASLANER AK MÜZEYYEN, SAHİP BİRSEN, GEDÜK AYFER, UÇAR MEHMET ALİ, Kale Hacer (6 more authors)
XIV. Eurasian Hematology Oncology Congress | Sözlü Sunum | Elektronik | 2023-10-11 - 2023-10-19 | 11.10.2023